TABLE 1

Recommended screening for retinopathy in patients on hydroxychloroquine

	Low-risk patients	Patients with risk factors^a
Initial screening	Within first year of therapy	Within first year of therapy
Repeat screening	After 5 years of therapy, then annually	Annually

↵a Higher medical dose, decreased renal function, tamoxifen use, or macular disease.
Based on information in references 27 and 28.